A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

    Contact: Study coordinator (Mingjun Zhang, MD)
  • Peking University Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Jian Fang, MD)
  • The First Medical Center of the Chinese People's Liberation Army General Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yi Hu, MD)
  • Cancer Hospital Affiliated to Guangzhou Medical University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Weidong Li, MD)
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Herui Yao, MD)
  • The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China

    Contact: Study coordinator (Zhong Lin)
    Contact: Study coordinator (Xiaofeng Pei)
  • Sun Yat-Sen University Cancer Center, Guangdong, Guangzhou, China

    Contact: Study coordinator (RuiHua XU, MD) · xurh@sysucc.org.cn · 020-87343533
  • Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China

    Contact: Study coordinator (Jingran Wang, MD)
  • Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang, China

    Contact: Study coordinator (Baogang Liu, MD) · 13804552752
  • The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

    Contact: Study coordinator (Shuangshuang Guo)
  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Quming Wang, MD)
  • Henan Provincial People's Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Shundong Cang, MD) · 13592675836
  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    Contact: Study coordinator (Xingya Li, MD) · 15618417071
  • Union Hospital, Tongji Medical College,Huazhong University of Science and Technology, Wuhan, Hubei, China

    Contact: Study coordinator (Xiaorong Dong, MD) · 13986252286
  • Hunan Cancer hospital, Changsha, Hunan, China

    Contact: Study coordinator (Lin Wu, MD) · 13170419973
  • Jiangsu Provincial People's Hospital, Nanjing, Jiangsu, China

    Contact: Study coordinator (Yongqian Shu, MD)
  • Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China

    Contact: Study coordinator (Yong Mao, MD) · 18651581690
  • The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China

    Contact: Study coordinator (Junhe Li, MD) · 13699505152
  • Affiliated Cancer Hospital of Shandong First Medical University, Jinan, Shandong, China

    Contact: Study coordinator (Zhehai Wang, MD)
  • Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

    Contact: Study coordinator (Jing Wang, MD)
  • Shanxi Cancer Hospital, Taiyuan, Shanxi, China

    Contact: Study coordinator (Hongxia Lu, MD)
  • Yunnan Cancer Hospital, Kunming, Yunnan, China

    Contact: Study coordinator (Runxiang Yang, MD)
  • Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Tao Li, MD)
  • The first affiliated hospital Zhejiang university school of medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Nong Xu, MD) · 0571-87236114